Valion Bio, Inc. Increase (Decrease) in Other Current Assets and Liabilities, Net
Valion Bio, Inc. (VBIO) reported Increase (Decrease) in Other Current Assets and Liabilities, Net of $2.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet · last filed 2025-08-14
- Valion Bio, Inc. increase (decrease) in other current assets and liabilities, net for the quarter ending 2025-06-30 was $0.00.
- Valion Bio, Inc. increase (decrease) in other current assets and liabilities, net for the quarter ending 2025-03-31 was $2.00K.
- Valion Bio, Inc. increase (decrease) in other current assets and liabilities, net for the quarter ending 2024-12-31 was $0.00.
- Valion Bio, Inc. increase (decrease) in other current assets and liabilities, net for the quarter ending 2024-09-30 was $0.00.
- Valion Bio, Inc. increase (decrease) in other current assets and liabilities, net for fiscal 2024 was -$34.00K.
| Period end | Increase (Decrease) in Other Current Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Current Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Current Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Current Assets and Liabilities, Net 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $2.00K 10-Q · filed 2025-08-14 | $2.00K derived: sum of 3 quarters · filed 2025-08-14 | $2.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | $2.00K 10-Q · filed 2025-05-15 | $2.00K derived: sum of 2 quarters · filed 2025-05-15 | $2.00K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $0.00 derived: sum of 2 quarters · filed 2025-03-21 | -$34.00K 10-K · filed 2025-03-21 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$34.00K 10-Q · filed 2024-11-14 | ||
| 2024-06-30 | -$34.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |